Skip to main content

Table 1 Patients characteristics, LOS and endpoints

From: Hospital costs fell as numbers of LVADs were increasing: experiences from Oslo University Hospital

    Pre-LVAD phase days) LVAD phase (days) Total in-hospital stay (days) End point
  Patient # Age (years) Sex LOS ECMO LOS LOS LOS ICU LOS
VA 1 64 M 20   22 25 42 Htx
VA 2 62 M 1   26 7 27
VA 3 15 F 8   26 6 34 Htx
VA 4 38 M 5 6 28 27 33 Htx
VA 5 23 M 8   32 10 40 Htx
VA 6 54 M 1 14 26 18 27 Htx †
VA 7 65 M 8   29 11 37 *
VA 8 16 F 15 23 42 13 57 *
VA 9 20 M 13   21 5 34 Htx
VA 10 59 M 14   88 35 102
VA 11 55 M 8   39 39 47
VA 12 53 F 12   32 21 44 Htx
VA 13 10 M 6   39 14 45 Htx
VA 14 19 M 49   42 17 91 Htx
VA 15 27 M 39 11 56 18 95 Htx
VA 16 29 M 2   125 56 127 Htx
VA 17 32 M 32   45 23 77 Htx
VA 18 21 M 44   25 14 69 Htx
VA 19 61 M 1   40 12 41 Htx
VA 20 16 M 8 4 4 12 12 Htx
HW 1 39 M 0 3 41 15 41 Htx
HW 2 72 M 5   42 21 47 Htx
HW 3 56 M 29   29 8 58 *
HW 4 62 F 11   31 12 42
HW 5 54 M 36   57 40 93 Htx
HW 7 61 M 6 7 27 9 33 Htx
HW 8 26 M 12   19 7 31 Htx
HW 10 35 M 17   40 6 57 Htx
HW 11 46 M 6   30 13 36 Htx
Mean 41   14 10 38 18 52  
Range (10-72)   (1-49) (3-23) (4-125) (5-56) (12-127)  
  1. VA VentrAssist™LVAD.
  2. HW HeartWare™LVAD.
  3. M Male.
  4. F Female.
  5. LOS (Length of Stay) in days.
  6. ECMO Extra Corporeal Membrane Oxygenation.
  7. ICU Intensive Care Unit.
  8. Htx Heart transplantation.
  9. End points: † = dead, * = on device.
  10. ^^ patient no 6 and 9 from the HeartWare LVAD study was excluded as patient had HW BIVAD.
  11. **Mean cost for ECMO is only for the patients with ECMO.